AAAAAA

   
Results: 1-15 |
Results: 15
Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis
Authors: de Visser, MCH Poort, SR Vos, HL Rosendaal, FR Bertina, RM
Citation: Mch. De Visser et al., Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis, THROMB HAEM, 85(6), 2001, pp. 1011-1017
Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels
Authors: Ceelie, H Bertina, RM Vlieg, AV Rosendaal, FR Vos, HL
Citation: H. Ceelie et al., Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels, THROMB HAEM, 85(6), 2001, pp. 1066-1070
Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of themouse TA3Ha mammary carcinoma cell
Authors: Thingstad, T Vos, HL Hilkens, J
Citation: T. Thingstad et al., Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of themouse TA3Ha mammary carcinoma cell, BIOCHEM J, 353, 2001, pp. 33-40
Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women
Authors: Psaty, BM Smith, NL Lemaitre, RN Vos, HL Heckbert, SR LaCroix, AZ Rosendaal, FR
Citation: Bm. Psaty et al., Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women, J AM MED A, 285(7), 2001, pp. 906-913
A STAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells
Authors: Gaemers, IC Vos, HL Volders, HH van der Valk, SW Hilkens, J
Citation: Ic. Gaemers et al., A STAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells, J BIOL CHEM, 276(9), 2001, pp. 6191-6199
High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene
Authors: Kamphuisen, PW Eikenboom, JCJ Rosendaal, FR Koster, T Blann, AD Vos, HL Bertina, RM
Citation: Pw. Kamphuisen et al., High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene, BR J HAEM, 115(1), 2001, pp. 156-158
A novel, possibly functional, single nucleotide polymorphism in the codingregion of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels
Authors: Brouwers, GJ Vos, HL Leebeek, FWG Bulk, S Schneider, M Boffa, M Koschinsky, M van Tilburg, NH Nesheim, ME Bertina, RM Garcia, EBG
Citation: Gj. Brouwers et al., A novel, possibly functional, single nucleotide polymorphism in the codingregion of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels, BLOOD, 98(6), 2001, pp. 1992-1993
Association of the alpha-adducin polymorphism with blood pressure and riskof myocardial infarction
Authors: Psaty, BM Doggen, C Vos, HL Vandenbroucke, JP Rosendaal, FR
Citation: Bm. Psaty et al., Association of the alpha-adducin polymorphism with blood pressure and riskof myocardial infarction, J HUM HYPER, 14(2), 2000, pp. 95-97
The HR2 haplotype of factor V is not associated with the risk of myocardial infarction
Authors: Doggen, CJM de Visser, MCH Vos, HL Bertina, RM Cats, VM Rosendaal, FR
Citation: Cjm. Doggen et al., The HR2 haplotype of factor V is not associated with the risk of myocardial infarction, THROMB HAEM, 84(5), 2000, pp. 815-818
The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis
Authors: de Visser, MCH Guasch, JF Kamphuisen, PW Vos, HL Rosendaal, FR Bertina, RM
Citation: Mch. De Visser et al., The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis, THROMB HAEM, 83(4), 2000, pp. 577-582
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions
Authors: Kamphuisen, PW Eikenboom, JCJ Vos, HL Pablo, R Sturk, A Bertina, RM Rosendaal, FR
Citation: Pw. Kamphuisen et al., Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions, THROMB HAEM, 81(5), 1999, pp. 680-683
No indication for APTT screening in patients on oral anticoagulant therapy
Authors: van der Meer, FJM Vos, HL Rosendaal, FR
Citation: Fjm. Van Der Meer et al., No indication for APTT screening in patients on oral anticoagulant therapy, THROMB HAEM, 81(3), 1999, pp. 364-366
Compound heterozygosity for one novel and one recurrent mutation in a Thaipatient with severe protein S deficiency
Authors: Pung-amritt, P Poor, SR Vos, HL Bertina, RM Mahasandana, C Tanphaichitr, VS Veerakul, G Kankirawatana, S Suvatte, V
Citation: P. Pung-amritt et al., Compound heterozygosity for one novel and one recurrent mutation in a Thaipatient with severe protein S deficiency, THROMB HAEM, 81(2), 1999, pp. 189-192
Lipopolysaccharide induction of Tissue Factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation
Authors: Hall, AJ Vos, HL Bertina, RM
Citation: Aj. Hall et al., Lipopolysaccharide induction of Tissue Factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation, J BIOL CHEM, 274(1), 1999, pp. 376-383
Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient
Authors: Poort, SR Njo, KT Vos, HL Bertina, RM
Citation: Sr. Poort et al., Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient, BL COAG FIB, 9(8), 1998, pp. 761-764
Risultati: 1-15 |